1. |
KOZAK, Andreja, MIKHAYLOV, Georgy, KHODAKIVSKYI, Pavlo, GOUN, Elena, TURK, Boris, VASILJEVA, Olga. A new cathepsin D targeting drug delivery system based on Immunoliposomes functionalized with lipidated pepstatin A. Pharmaceutics. [Online ed.]. 2023, vol. 15, no. 10, str. 2464-1-2464-11. ISSN 1999-4923
|
2. |
MIKHAYLOV, Georgy, MIKAC, Urška, BUTINAR, Miha, TURK, Vito, TURK, Boris, PSAKHIE, Sergey, VASILJEVA, Olga. Theranostic applications of an ultra-sensitive T1 and T2 magnetic resonance contrast agent based on Cobalt ferrite spinel nanoparticles. Cancers. 2022, vol. 14, no. 16, str. 4026-1-4026-14. ISSN 2072-6694
|
3. |
BONI, Valentina, VASILJEVA, Olga, et al. Praluzatamab ravtansine, a CD166-Targeting antibody–drug conjugate, in patients with advanced solid tumors : an open-label phase I/II trial. Clinical cancer research. [Print ed.]. 2022, vol. 28, no. 10, str. 2020-2029. ISSN 1078-0432
|
4. |
SINGHAL, Shweta, VASILJEVA, Olga, et al. Nonclinical efficacy and safety of CX-2029, an anti-CD71 probody–drug conjugate. Molecular cancer therapeutics. [Online ed.]. 2022, vol. 21, no. 8, str. 1326-1-1336. ISSN 1538-8514
|
5. |
TSUKANOV, Alexey A., TURK, Boris, VASILJEVA, Olga, PSAKHIE, Sergey. Computational indicator approach for assessment of nanotoxicity of two-dimensional nanomaterials. Nanomaterials. [Online ed.]. 2022, vol. 12, no. 4, str. 650-1-650-19. ISSN 2079-4991
|